The Department of Veterans Affairs Headquarters awarded Akesogen, Inc. Tempus Labs, Inc. Division, a for-profit organization, a Firm Fixed Price Delivery Order contract worth $9,874,980.00 to provide genomic analysis services. The contract, with a performance period ending March 20, 2024, tasks Tempus Labs with conducting genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services at the VA Headquarters in...
This is a $4,000,000.00 firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters to Akesogen, Inc.'s Tempus Labs, Inc. division for genomic analysis services. The contract has a period of performance through July 21, 2025 and is not designated as a set-aside. Tempus Labs, a for-profit technology company, will provide genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular...
This is a firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters (VA HQ) to Akesogen, Inc.'s Tempus Labs division. The contract, valued at $10,477,738.83, tasks Tempus Labs with providing genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services in support of the VA's biomedical research programs. The work is performed at the VA HQ in Washington, D.C. with...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $6,049,896.00 Firm Fixed Price Delivery Order contract to Akesogen, Inc. Tempus Labs, Inc. Division for genomic sequencing and analysis services. This contract, which does not have a set-aside designation, is in support of the VA's biomedical research programs, including the Million Veteran Program research initiative. Akesogen, Inc. Tempus Labs, Inc. Division has previously held delivery order contracts with the VA...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Akesogen, Inc.'s Tempus Labs, Inc. division. The contract, valued at $3,750,584.00, is for genotyping services to support the VA's biomedical research programs, including the Million Veteran Program. Akesogen, Inc. Tempus Labs, Inc. division has provided similar genomic analysis services to the VA in the past through delivery order contracts ranging from $6.4 million to $13...
<p>The Department of Veterans Affairs Headquarters awarded a $6.4 million firm fixed price delivery order contract to Akesogen, Inc. Tempus Labs, Inc. Division for Genomic Analysis services. The contract has a period of performance starting on September 30, 2023 through September 29, 2025 and will be performed in Washington, D.C.</p>
The Department of Veterans Affairs (VA) awarded a $3,749,937.00 firm-fixed-price delivery order contract to Akesogen, Inc. (operating through its Tempus Labs, Inc. division) for genotyping services. This delivery order is part of a larger $111 million Indefinite Delivery Contract (IDC) originally awarded to Akesogen in September 2020. The contract supports the VA's Million Veteran Program, a biomedical research initiative analyzing over 800,000 veteran DNA samples, and was originally procured on...
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Akesogen, Inc., operating through its Tempus Labs, Inc. division. The $3,749,984.00 firm-fixed-price contract is for genotyping services to support the VA's Million Veteran Program, a large-scale biomedical research initiative analyzing over 800,000 veteran DNA samples. The contract was awarded on a total small business set-aside basis in September 2016, with a period of performance through September 2018. Akesogen...
Tempus Labs Inc. is providing tumor normal matched genomic testing services to the Department of Veterans Affairs (VA) under a $5,999,647 firm fixed price delivery order. This order was issued against an Indefinite Delivery contract held by Tempus with the VA worth up to $64 million for such services. Through January 2027, Tempus will analyze genomic sequencing data from veteran cancer patients' tumor and normal tissue samples to help inform precision medicine treatment decisions within the VA...
This contract was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Akesogen, Inc.'s Tempus Labs division for DNA extraction services. The $5,286.10 firm-fixed-price purchase order does not have a set-aside designation. Tempus Labs is a for-profit technology company that specializes in advanced genomic analysis services, primarily supporting large-scale biomedical research programs conducted by federal agencies like the Department of...